Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Acquisitions (2019 - 2025)

AdaptHealth (AHCO) has 7 years of Acquisitions data on record, last reported at $23.8 million in Q4 2025.

  • For Q4 2025, Acquisitions rose 149.76% year-over-year to $23.8 million; the TTM value through Dec 2025 reached $33.4 million, up 249.76%, while the annual FY2025 figure was $42.4 million, 344.4% up from the prior year.
  • Acquisitions reached $23.8 million in Q4 2025 per AHCO's latest filing, up from $9.5 million in the prior quarter.
  • Across five years, Acquisitions topped out at $1.2 billion in Q1 2021 and bottomed at $12000.0 in Q3 2023.
  • Average Acquisitions over 5 years is $120.9 million, with a median of $11.0 million recorded in 2022.
  • Peak YoY movement for Acquisitions: skyrocketed 6956.91% in 2021, then tumbled 99.75% in 2022.
  • A 5-year view of Acquisitions shows it stood at $202.4 million in 2021, then tumbled by 98.58% to $2.9 million in 2022, then tumbled by 38.61% to $1.8 million in 2023, then surged by 438.76% to $9.5 million in 2024, then surged by 149.76% to $23.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Acquisitions were $23.8 million in Q4 2025, $9.5 million in Q4 2024, and $1.8 million in Q4 2023.